1-3 of 3
Sewa Rijal
Close
Sort by
Journal Articles

The Genetic Landscape in Elderly DLBCL Aged > 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations

Sewa Rijal, Jun Hee Lim, PhD, Lillian Smyth, Caitlin Coombes, MChD, Sanjiv Jain, MBBS, Kartik Saxena, PhD, Judith Trotman, FRACP, Emma Verner, MBBS, FRACP, FRCPA, Maher K. Gandhi, PhDFRACP,FRCPath, Kaushal Gandhi, PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–20.
https://doi.org/10.1182/blood-2020-141795
Published: 2020
Journal Articles

Somatic Mutations Associated with IgV H 4-34 FR1 Region Unmutated QW and Avy Motifs in DLBCL Patients

Caitlin Coombes, MChD, Keisuke Horikawa, MD PhD, Sanjiv Jain, MBBS, Jun Hee Lim, PhD, Sewa Rijal, Kartik Saxena, PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-142486
Published: 2020
Journal Articles

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML

Clinical Trials & Observations
Sewa Rijal, Shaun Fleming, Nik Cummings, Natalie K. Rynkiewicz, Lisa M. Ooms, Nhu-Y. N. Nguyen, Tse-Chieh Teh, Sharon Avery, Julie F. McManus, Anthony T. Papenfuss, Catriona McLean, Mark A. Guthridge, Christina A. Mitchell, Andrew H. Wei
Journal: Blood
Blood (2015) 125 (18): 2815–2824.
https://doi.org/10.1182/blood-2014-09-603555
Published: 2015
Includes: Supplemental data